ArticlebioRxiv : the preprint server for biology2020
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic.
Maria Alimova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.